Exploring Renal Transplants Using Hepatitis C Infected Donors for HCV-negative Recipients

NCT02781649 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

End-Stage Renal Disease
Hepatitis C

Interventions

DRUG: Zepatier
DRUG: Ribavirin
DRUG: Sofosbuvir

Sponsor

Johns Hopkins University

Collaborators

[object Object]